Clinical Trial of Inhaled Molgramostim Nebulizer Solution in Autoimmune Pulmonary Alveolar Proteinosis (aPAP)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
54 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Royal Prince Alfred Hospital
Camperdown, New South Wales, Australia
- Westmead Hospital
Westmead, New South Wales, Australia
- Hôpital Erasme
Brussels, Brussels Capital, Belgium
- Uz Leuven - Campus Gasthuisberg - Pneumologie
Leuven, Vlaams Brabant, Belgium
- University of Calgary
Calgary, Alberta, Canada
- St Joseph'S Healthcare Hamilton Research
Hamilton, Ontario, Canada
- University Institute of Cardiology and Respirology of Quebec
Québec, Canada
- Hôpital Louis Pradel
Bron, Auvergne-Rhône-Alpes, France
- Chu Pontchaillou
Rennes, Brittany Region, France
- Thoraxklinik Heidelberg Ggmbh Am Universitätsklinikum Heidelberg
Heidelberg, Baden-Wurttemberg, Germany
- Asklepios Fachkliniken Muenchen-Gauting
Muenchen-Gauting, Bavaria, Germany
- Ruhrlandklinik Westdeutsches Lungenzentrum
Essen, North Rhine-Westphalia, Germany
- Attikon University Hospital
Athens, Greece
- St. Vincent'S University Hospital
Dublin, Ireland
- Fondazione Irccs Policlinico San Matteo
Pavia, Lombardy, Italy
- Hokkaido University Hospital
Sapporo, Hokkaidô, Japan
- Kanagawa Cardiovascular and Respiratory Center
Yokohama, Kanagawa, Japan
- Tohoku University Hospital - Respiratory Tract Medicine
Sendai, Miyagi, Japan
- National Hospital Organization Kinki-Chuo Chest Medical Center
Sakai, Osaka, Japan
- Kyorin University Hospital
Mitaka, Tokyo, Japan
- Chiba University Hospital - Respiratory Medicine
Chiba, Japan
- Kumamoto University Hospital
Kumamoto, Japan
- Aichi Medical University Hospital
Nagakute, Japan
- Saitama Red Cross Hospital
Saitama, Japan
- St Antonius Hospital
Nieuwegein, Utrecht, Netherlands
- Instytut Gruzlicy I Chorob Pluc
Warsaw, Masovian Voivodeship, Poland
- Hospital Pulido Valente
Lisbon, Portugal
- Hospital São João
Porto, Portugal
- Institutul de Pneumoftiziologie "marius Nasta"
Bucharest, Romania
- Asan Medical Center
Seoul, South Korea
- Samsung Medical Center
Seoul, South Korea
- Seoul National University Hospital
Seoul, South Korea
- Severance Hospital - Yonsei University Health System - Pulmonary
Seoul, South Korea
- Hospital Universitario de Bellvitge
Barcelona, Catalonia, Spain
- Ege University Hospital - Department of Pulmonology
Bornova, İzmir, Turkey (Türkiye)
- Health Sciences University Gulhane Training and Research Hospital
Ankara, Turkey (Türkiye)
- Yedikule Chest Disease and Surgery Training and Research Hospital
Istanbul, Turkey (Türkiye)
- Royal Brompton and Harefield Nhs Foundation Trust
London, United Kingdom
- University of Arkansas for Medical Services
Little Rock, Arkansas, United States
- Ucla David Geffen School of Medicine
Los Angeles, California, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 19 May 2021
- Primary completion
- 30 Nov 2023
- Completion
- 30 May 2027
- Last update posted
- 7 Aug 2025
- Registered enrollment
- 164
- Registry id
- NCT04544293
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.